Operating cash flow swung from +$562.5M in Q1 2026 to -$189.9M in Q2 2026, driven by a $624.5M reversal in working capital, while FCF margin collapsed from 40.3% to -29.5%.
AMN Healthcare Services, Inc. (AMN) cash flow statement — 26-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Cash from Operations | 470.76M | 269.46M | 320.42M | 372.17M | 653.73M | 305.36M | 256.83M | 224.86M | 226.99M | 115.26M | 131.85M | 57.05M | 27.68M | 58.64M | 60.51M | 19.31M | 8.09M | 98.73M | 63.69M | 79.64M | 54.54M | 44.09M | 39.04M | 65.14M | 56.85M | 1.68M | -1.59M |
| Operating CF Margin % | - | 9.87% | 10.74% | 9.82% | 12.47% | 7.66% | 10.73% | 10.12% | 10.63% | 5.8% | 6.93% | 3.9% | 2.67% | 5.8% | 6.34% | 2.18% | 1.17% | 12.99% | 5.23% | 6.84% | 5.04% | 6.25% | 6.21% | 9.12% | 7.33% | 0.32% | -0.69% |
| Operating CF Growth % | 102.9% | -15.9% | -13.9% | -43.07% | 114.09% | 18.9% | 14.21% | -0.94% | 96.94% | -12.58% | 131.1% | 106.13% | -52.8% | -3.1% | 213.34% | 138.74% | -91.81% | 55.01% | -20.02% | 46.02% | 23.7% | 12.94% | -40.08% | 14.59% | 3286.12% | 205.86% | - |
| Net Income | 104.92M | -95.7M | -146.98M | 210.68M | 444.05M | 327.39M | 70.67M | 113.99M | 141.74M | 132.56M | 105.84M | 81.89M | 33.22M | 32.93M | 15.95M | -26.27M | -51.99M | -122.18M | 34.36M | 36.53M | 35.09M | 22.23M | 17.35M | 37.79M | 52.36M | -4.39M | -5.2M |
| Depreciation & Amortization | 146.62M | 156.6M | 173.78M | 160.93M | 137.11M | 103.7M | 94.19M | 58.52M | 41.24M | 32.28M | 29.62M | 20.95M | 15.99M | 13.54M | 14.15M | 16.42M | 15.08M | 13.81M | 14.44M | 11.67M | 10.32M | 6.18M | 5.84M | 4.82M | 3.84M | 7.71M | 3.3M |
| Stock-Based Compensation | 32.21M | 30.68M | 23.32M | 18.02M | 30.07M | 25.22M | 20.46M | 16.24M | 10.81M | 10.24M | 11.4M | 10.28M | 7.16M | 6.13M | 6.22M | 7.13M | 8.28M | 8.71M | 9.32M | 8.39M | 6.8M | 142K | 16.1K | 874K | 31.88M | 31.88M | 0 |
| Deferred Taxes | 11.37M | -19.55M | -51.07M | -12.93M | -24.61M | -16.29M | -21.63M | 913K | -667K | 5.61M | -9.42M | 12.68M | 11.78M | 3.03M | 6.95M | -1.79M | -10.71M | -51.72M | -3.37M | 1.14M | 18.08M | 19.02M | 4.09M | 6.04M | 7.29M | -8.65M | -9.73M |
| Other Non-Cash Items | -31.2M | 96.39M | 235.46M | 45.6M | 67.68M | 8.84M | 26.01M | 16.22M | 2.25M | 12.85M | 11.12M | 1.58M | 7.14M | 1.84M | 19.51M | 47.67M | 57.98M | 185.6M | 1.76M | 2.13M | -2.74M | 4.48M | 2.44M | 1.6M | -27.58M | 14.28M | 27.02M |
| Working Capital Changes | 206.84M | 101.03M | 85.91M | -50.13M | -558K | -143.49M | 67.13M | 18.98M | 31.61M | -78.27M | -16.7M | -70.33M | -47.61M | 1.16M | -2.27M | -23.84M | -10.56M | 64.51M | 7.18M | 19.77M | -13.01M | -7.96M | 9.32M | 14.02M | -10.94M | -39.16M | -16.98M |
| Change in Receivables | 24.92M | 74.75M | 219.44M | 224.85M | 20.04M | -585.27M | -8.61M | 5.71M | -10.58M | -10.64M | -57.16M | -98.02M | -52.13M | -8.45M | 1.39M | -29.02M | -15.3M | 88.73M | 10.41M | 5.53M | -40.6M | -474K | 0 | -30.15M | -39.48M | -39.48M | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | -256.12M | -5.56M | -1.93M | 14.56M | -32.63M | -3.34M | -7.34M | -4M | 4.33M | -12.29M | 5.6M | 1.16M | 0 | -6.91M | 8.57M | 23.83M | -106.36M | 0 | -36.48M | -111.42M | -118.81M | 0 |
| Change in Payables | 31.17M | -20.57M | 0 | 0 | 0 | 256.12M | 5.56M | 1.93M | 17.15M | -7.86M | 17.7M | 29.61M | 6.13M | 4.34M | 2.83M | 3.66M | 8.94M | 0 | 1.94M | 1.72M | 1.18M | -1.2M | 0 | 3.66M | 2.65M | 2.65M | 0 |
| Cash from Investing | 31.23M | 4.3M | -79.94M | -412.49M | -170.71M | -107.4M | -538.17M | -291.82M | -279.34M | -33.45M | -257.36M | -116.83M | -28.23M | -47.9M | 2.96M | -1.98M | -6.85M | -29.25M | -48.25M | -14.63M | -45.68M | -115.33M | -5.06M | -14.01M | 1.45M | -33.78M | -94.14M |
| Capital Expenditures | -32.14M | -35.63M | -80.89M | -103.69M | -75.83M | -53.66M | -39.1M | -36.46M | -36.39M | -26.53M | -21.96M | -27.01M | -19.13M | -9.05M | -5.47M | -4.65M | -4.17M | -3.79M | -8.79M | -9.15M | -9.71M | -3.82M | -5.06M | -13.01M | -4.33M | -4.5M | -2.36M |
| CapEx % of Revenue | 0.94% | 1.3% | 2.71% | 2.74% | 1.45% | 1.35% | 1.63% | 1.64% | 1.7% | 1.33% | 1.15% | 1.85% | 1.85% | 0.89% | 0.57% | 0.52% | 0.6% | 0.5% | 0.72% | 0.79% | 0.9% | 0.54% | 0.8% | 1.82% | 0.56% | 0.87% | 1.02% |
| Acquisitions | -3.03M | 65.28M | 0 | -292.1M | -69.5M | -41.26M | -476.43M | -247.91M | -217.36M | -1.5M | -218.34M | -85.07M | -14.47M | -39.5M | 0 | 0 | -3.23M | 0 | -30.95M | -5.48M | -35.96M | -111.51M | 0 | -9.53M | -9.53M | -12.97M | -91.79M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 64.69M | 22K | -6.76M | -26.6M | -26.61M | -8.99M | -7.66M | -13.29M | -10.67M | -8.62M | -5.91M | -3M | 10.38M | 647K | 8.43M | 2.67M | 553K | -25.46M | -8.5M | 0 | 0 | 0 | 0 | -1M | 15.31M | -19.09M | 8K |
| Cash from Financing | -183.96M | -295.89M | -259.45M | 10.73M | -591.87M | -34.9M | 211.49M | 136.6M | 37.51M | -77.19M | 126.29M | 56.2M | -2.1M | -783K | -61.68M | -15.3M | -26.45M | -53.81M | -22.33M | -50.92M | -23.54M | 86.52M | -34.75M | -86.47M | -33.82M | 47.21M | 95.77M |
| Debt Issued (Net) | -170M | -285M | -250M | 459.7M | 0 | -21.88M | 240.54M | 180M | 120M | -44.06M | 149.68M | 57M | 2.23M | -681K | -53.73M | -12.5M | -21.86M | -53.65M | 2.04M | -37.92M | -21.81M | 89.11M | -36.42M | 137.37M | -662K | -128.87M | 45.18M |
| Equity Issued (Net) | -5.04M | -2.09M | -8.47M | -424.74M | -576.77M | -2.69M | -6.93M | -18.7M | -67.01M | -20.16M | -13.26M | 0 | 0 | 0 | 530K | 0 | 0 | 0 | -28.45M | -16.29M | -10.58M | 2.32M | 1.93M | -219.21M | -33.06M | 177.34M | 52M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -5.04M | -2.09M | -8.47M | -424.74M | -576.77M | -2.69M | -6.93M | -18.7M | -67.01M | -20.16M | -13.26M | -11.91M | -4.45M | -2.67M | -1.07M | 0 | 0 | 0 | -28.45M | -18.51M | -37.53M | 0 | -110K | -219.26M | -35.16M | 0 | 0 |
| Other Financing | -8.92M | -8.8M | -9.45M | -24.23M | -15.1M | -10.33M | -22.13M | -24.7M | -15.48M | -12.97M | -10.13M | -796K | -4.33M | 262K | -8.48M | -2.8M | -4.59M | -156K | 4.07M | 3.29M | 8.86M | -4.9M | -258K | -4.63M | -101K | -1.26M | -1.41M |
| Net Change in Cash | 323.59M | -22.13M | -18.97M | -29.6M | -108.84M | 162.72M | -69.97M | 69.64M | -14.57M | 4.53M | 1.05M | -3.5M | -2.51M | 9.9M | 1.72M | 2.08M | -25.17M | 15.74M | -7.18M | 14.07M | -14.69M | 15.2M | -779K | -35.45M | 24.48M | 15.11M | 43K |
| Free Cash Flow | 439.13M | 233.83M | 239.53M | 266.78M | 572.81M | 251.69M | 217.72M | 188.4M | 190.61M | 88.73M | 109.89M | 30.04M | 8.54M | 49.59M | 55.04M | 14.66M | 3.92M | 94.94M | 54.9M | 70.48M | 44.82M | 40.27M | 33.98M | 52.13M | 52.52M | -2.82M | -3.94M |
| FCF Margin % | 12.79% | 8.56% | 8.03% | 7.04% | 10.92% | 6.32% | 9.1% | 8.48% | 8.92% | 4.46% | 5.78% | 2.05% | 0.82% | 4.9% | 5.77% | 1.65% | 0.57% | 12.5% | 4.51% | 6.06% | 4.14% | 5.71% | 5.4% | 7.3% | 6.77% | -0.54% | -1.71% |
| FCF Growth % | 71.88% | -2.38% | -10.21% | -53.43% | 127.58% | 15.6% | 15.56% | -1.16% | 114.81% | -19.26% | 265.79% | 251.63% | -82.77% | -9.9% | 275.34% | 273.99% | -95.87% | 72.94% | -22.11% | 57.25% | 11.3% | 18.53% | -34.83% | -0.75% | 1963.91% | 28.55% | - |
| FCF per Share | 11.05 | 6.07 | 6.27 | 6.78 | 12.77 | 5.24 | 4.57 | 3.96 | 3.92 | 1.80 | 2.23 | 0.62 | 0.18 | 1.04 | 1.18 | 0.32 | 0.11 | 2.91 | 1.62 | 2.02 | 1.30 | 1.25 | 1.08 | 1.31 | 1.12 | -0.09 | -0.18 |
| FCF Conversion (FCF/Net Income) | 4.19x | -2.82x | -2.18x | 1.77x | 1.47x | 0.93x | 3.63x | 1.97x | 1.60x | 0.87x | 1.25x | 0.70x | 0.83x | 1.78x | 3.53x | -0.74x | -0.16x | -0.81x | 1.85x | 2.18x | 1.55x | 1.98x | 2.25x | 1.72x | 1.09x | -0.38x | 0.31x |
| Interest Paid | 29.32M | 45.11M | 61.03M | 48.1M | 37.52M | 38.09M | 22.65M | 23.73M | 21.28M | 17.94M | 8.06M | -5.81M | 4.6M | 7.41M | 13.7M | 19.67M | 16.43M | 7.39M | 9.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 41.46M | 7.85M | 28.15M | 78.26M | 213.81M | 106.38M | 46.26M | 37.75M | 30.59M | 73.75M | 73.37M | -33.13M | 17.88M | 18.86M | 1.86M | 388K | 84K | 5.61M | 32.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying AMN stock.
AMN Healthcare Services, Inc. (AMN) generated $269.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
AMN Healthcare Services, Inc. (AMN) generated $233.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
AMN Healthcare Services, Inc. (AMN) spent $35.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, AMN Healthcare Services, Inc. (AMN) spent $2.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Working capital volatility and earnings quality
Metrics are mathematically derived from official filings.
Cash Conversion Disconnect Deepens
In Q2 2026, AMN reported net income of $21.2M but operating cash flow of -$189.9M, an OCF/NI ratio of -8.98, indicating a severe cash conversion breakdown.
The negative operating cash flow despite positive net income suggests that working capital outflows, particularly a $215.1M working capital swing, overwhelmed earnings. This may indicate aggressive revenue recognition or timing issues in collections, warranting scrutiny of the quality of earnings. The prior quarter's OCF/NI of 9.05 highlights extreme quarter-to-quarter volatility, suggesting that cash generation is not reliably tracking profitability.
FCF Swing Highlights Instability
Free cash flow swung from $555.2M in Q1 2026 to -$198.5M in Q2 2026, with FCF margin collapsing from 40.3% to -29.5%, per reported figures.
The dramatic reversal in FCF is driven by the working capital swing, not capex, which remained stable around $9M. This suggests that AMN's cash flow is highly sensitive to the timing of receivables and payables, likely reflecting hospital clients' payment behavior. The negative FCF in Q2 2026 may indicate that the company is funding growth or absorbing delayed collections, but the sustainability of such swings is questionable.
Working Capital Volatility Drives Cash Flow
Working capital changes swung from +$409.4M in Q1 2026 to -$215.1M in Q2 2026, a $624.5M reversal, per the cash flow statement.
This extreme volatility suggests that AMN's cash conversion cycle is highly unstable, possibly due to large contract timing or changes in hospital payment behavior. The positive working capital in Q1 may have been a one-time collection of receivables, while Q2's negative swing could indicate a build-up in receivables or a drawdown in payables. Investors should monitor DSO trends, as this pattern may signal deteriorating collection efficiency or aggressive revenue recognition.
Capex Discipline Amidst Revenue Decline
Capital expenditures have been consistently reduced from $27.3M in Q2 2024 to $9.0M in Q2 2026, with capex/revenue falling from 3.7% to 1.3%.
The significant reduction in capex suggests management is prioritizing cash preservation over growth investments, which may be appropriate given the revenue contraction. However, this could also indicate underinvestment in technology and infrastructure, potentially undermining the company's long-term competitive position. The low capital intensity relative to revenue implies that the business model is asset-light, but the sustainability of this approach depends on whether the technology segment requires more investment.
Cumulative Earnings vs Cash Reality
Over the last ten quarters, cumulative net income is -$139.1M while cumulative operating cash flow is $902.5M, a divergence of over $1 billion.
The large cumulative gap between net income and operating cash flow suggests that non-cash charges, such as impairments and depreciation, are significant, but also that working capital has been a major source of cash. This may indicate that the company has been liquidating working capital to support cash flow, which is not sustainable. The negative cumulative net income underscores persistent profitability challenges, while the positive cash flow may be masking underlying operational weakness.
What the Cash Flow Statement Obscures
Stock-based compensation of $9.8M in Q2 2026 is a non-cash expense that inflates operating cash flow relative to net income, but the $215.1M working capital swing is the primary distortion.
The cash flow statement highlights the working capital swings, but it does not reveal the underlying drivers, such as changes in DSO or payment terms. The negative net margin of -3.5% despite positive operating cash flow in most quarters suggests that cash flow is being supported by working capital liquidation, not core profitability. Investors should be cautious about interpreting operating cash flow as a sign of health, as it may be masking the deterioration in earnings quality.